Lived experiences of female patients aged 15-49 years undergoing treatment for multi-drug resistant tuberculosis (MDR-TB) in Lira Regional Referral Hospital, Uganda
Date
2024-01-16
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Taylor & Francis
Abstract
Multidrug-resistant tuberculosis (MDR-TB) is a major public health
hazard on a global scale. It is a kind of tuberculosis (TB) infection produced by
bacteria resistant to at least two of the most effective first-line anti-tuberculosis
(anti-TB) drugs: isoniazid and rifampicin. In numerous health care facilities
around Uganda, MDR-TB patients have bad experiences. The purpose of this
study was to investigate the lived experiences of female patients aged 15 to
49 years receiving treatment for MDR-TB at Lira Regional Referral Hospital,
Uganda. Using a method of purposive sampling, a phenomenological qualitative
study was done among female patients aged 15 to 49 receiving treatment for
multidrug-resistant tuberculosis at Lira Regional Hospital. Data was collected
using an English-translated Lango guide for in-depth interviews. Data was
entered manually and analyzed using version 13 of the qualitative program
NVIVO. It was discovered that the spouses of female MDR-TB patients lacked
social support. Female patients with a history of tuberculosis prior to MDR-TB had stronger family support systems. MDR-TB diagnosis was strongly related with
shock, anxiety, and denial. The majority of patients indicated that proper information on probable side effects allowed them to successfully complete MDR-TB
treatment. Compared to other health centres in the district, the MDR-TB services
at Lira Regional Referral were easily accessible and staffed by friendly medical
personnel. In conclusion, female patients receiving MDR-TB treatment represent
a unique population, and family support and care had a significant impact on the
success of MDR-TB treatment among them.
Description
Keywords
Multi-drug resistant TB, Isoniazid, Rifampicin, Lived experiences, Health conditions, Public health policy and practice, Medicine